Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study

D De Mouy; J D Cavallo; R Leclercq; R Fabre; AFICORPI-BIO Network. Association de Formation Continue en Pathologie Infectieuse des Biologistes

doi:10.1128/AAC.45.8.2400-2402.2001

Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae: French multicenter study

Antimicrob Agents Chemother. 2001 Aug;45(8):2400-2. doi: 10.1128/AAC.45.8.2400-2402.2001.

Authors

D De Mouy¹, J D Cavallo, R Leclercq, R Fabre; AFICORPI-BIO Network. Association de Formation Continue en Pathologie Infectieuse des Biologistes

Affiliation

¹ Association de Formation Continue en Pathologie Infectieuse des Biologistes, 75005 Paris, France.

Abstract

Among 126 Streptococcus agalactiae isolates collected in 10 French laboratories in 1999, 27 (21.4%) had macrolide resistance related to the presence of erm(B) (11 strains), erm(A) subclass erm(TR) (10 strains), and mef(A) genes (2 strains) and the presence of combinations of erm(B) and erm(A) genes or mef(A) genes (3 strains).

Publication types

Multicenter Study

MeSH terms

Anti-Bacterial Agents / pharmacology*
Drug Resistance, Microbial / genetics
Erythromycin / pharmacology*
France
Genes, Bacterial / physiology*
Humans
Microbial Sensitivity Tests*
Streptococcus agalactiae / drug effects*
Streptococcus agalactiae / genetics
Streptococcus agalactiae / isolation & purification

Substances

Anti-Bacterial Agents
Erythromycin